Pilot study of home self-administration of subcutaneous depo-medroxyprogesterone acetate for contraception
Authors:
- Sharon T. CameronSCSharon T. Cameron
- Anna GlasierAGAnna Glasier
- Anne JohnstoneAJAnne Johnstone
- 1 May 2012
- journal article
- Published by Elsevier in Contraception
- Vol. 85 (5) , 458-464
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Pharmacist-administered subcutaneous depot medroxyprogesterone acetate: a pilot randomized controlled trialContraception, 2010
- Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral densityContraception, 2009
- Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mgContraception, 2006
- Self-injection of monthly combined hormonal contraceptiveContraception, 2006
- Safety and side effects of the insulin analoguesExpert Opinion on Drug Safety, 2005
- The acceptability of self-administration of subcutaneous Depo-ProveraContraception, 2005
- Contraceptive efficacy and safety of DMPA-SCContraception, 2004
- Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera®Contraception, 2004
- Patient and physician satisfaction with the Humulin®/Humalog® Pen, a new 3.0-mL prefilled pen device for insulin deliveryClinical Therapeutics, 2000
- Self-administration with UniJect® of the once-a-month injectable contraceptive Cyclofem®Contraception, 1997